For large-scale indoor air treatment testing, partner with ÌìÃÀ´«Ã½ to meet consumer and industry demand for air treatments with antimicrobial public health claims. This commercial indoor air quality testing facility is among the first - and largest - designed for real world modeling of aerosolized disinfectant and sanitation products in indoor spaces.
It is now possible to evaluate the efficacy of aerosolized products intended to reduce or eliminate indoor airborne organisms in large indoor spaces such as arenas, hospitals, schools, transportation, and more. Unlike traditional microbiology test methods, ÌìÃÀ´«Ã½’s 214 cubic meter biocontainment laboratory allows for simultaneous testing of a control and treated space. Various size configurations of, but not limited to, 107m3 and 214m3 can be accommodated, in addition to multiple air handling scenarios, including recirculation and the introduction of fresh air.
Air treatment and related testing services for antimicrobial and antiviral products
A number of bacteria and viruses can be tested in ÌìÃÀ´«Ã½’s large BSL-2 testing facility, including SARS-CoV-2-like organisms. Complete our request form to get in touch with a scientist to explore available organisms. Common tests include, but are not limited to:
- Bioaerosol testing for air sanitization and air disinfection claims following EPA guidance
- Bioaerosol testing for virucidal claims in air
- Biological aerosol testing for removal of organisms in air
- Bioaerosol testing against bacteria, phage, mammalian viruses, and fungi
- Chemical analysis of air samples
- Research and development (R&D) level testing
- Good Laboratory Practices (GLP) compliant testing for regulatory submissions
- Testing that incorporates air exchanges during testing
- Custom testing against other air quality aerosols
- Testing antimicrobial devices against bioaerosols (air filters, UVC devices, in-duct products, etc.)
- Fogging and misting tests against airborne organisms
- Fogging and misting tests against organisms on surfaces
Achieve public health air quality claims for indoor spaces
Evaluate product performance with purposefully designed R&D protocols before engaging in GLP-compliant testing. Prepare for the imminent release of EPA guidance for the efficacy of air treatments for public health claims, expected as early as the end of 2022.
The ÌìÃÀ´«Ã½ advantage
ÌìÃÀ´«Ã½ is fully invested in the success of our customers, including bringing forth new and innovative capabilities and solutions to help them to meet evolving market demands. Navigate complex regulatory requirements and an ever-evolving market successfully with the support of the scientific and regulatory experts at ÌìÃÀ´«Ã½. Establish, maintain, and grow market share with air treatment products that have been validated by ÌìÃÀ´«Ã½ to provide public health improvements.
To learn more about our bioaerosol testing capabilities or to request a quote, fill out a short form.
Learn more
Virology Testing
ÌìÃÀ´«Ã½ offers GLP and cGMP virology testing options to serve our clients in the antimicrobial and pharmaceutical industries.
Microbiology Testing
ÌìÃÀ´«Ã½ offers a diverse array of microbiology testing services and can serve clients from early-stage antimicrobial product development and non-GLP screen testing all the way through GLP testing for submission.
About ÌìÃÀ´«Ã½ Eagan
ÌìÃÀ´«Ã½ Eagan is the premier contract antimicrobial testing laboratory and expert partner to the developers, manufacturers and users of antimicrobial pesticide and biocide products. We have more than 30 years of experience generating GLP-compliant data.
Client Portal
Secure 24/7 access to your test result information, which you can download directly to your information management system.